Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Influence of weight reduction by sibutramine on female sexual function

International Journal of Obesity volume 30, pages 758–763 (2006)Cite this article

Abstract

Background:

It is well known that selective serotonin reuptake inhibitors (SSRIs) can cause sexual dysfunction, so it is possible that sibutramine, a serotonin and norepinephrine reuptake inhibitor, could induce sexual dysfunction.

Design and subjects:

The effect of sibutramine on sexual function was evaluated in 46 overweight and obese (body mass index (BMI) ⩾23 kg/m2) but otherwise healthy married women (28–44 years). Participants were randomly assigned at baseline to either the sibutramine or control group. The Female Sexual Function Index (FSFI) questionnaire was used to assess sexual function at baseline and after treatment with behavioral therapy plus sibutramine 10 mg once daily or behavioral therapy alone (control) for 8 weeks.

Results:

Mean weight loss from baseline to week 8 was −6.03% in sibutramine group and −0.38% in the control group. There was significant improvement of FSFI total score, arousal domain score and lubrication domain score in the sibutramine group (P<0.05), and significant differences in arousal, orgasm, satisfaction domain score and total score (P<0.05) in favor of sibutramine. Decreases in body weight and BMI were correlated with the improvement of arousal (r=−0.44 and r=−0.48, respectively) and orgasm (r=−0.45 and r=−0.46, respectively) domains.

Conclusion:

Treatment with sibutramine plus behavioral therapy did not induce sexual dysfunction and sibutramine-induced weight reduction appeared to have a positive impact on sexual function in this small group of overweight and moderately obese women. The degree of improvement in sexual function was correlated with the degree of weight reduction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th edn. American Psychiatric Association: Washington, DC, 1994.

  2. Brassil DF, Keller M . Female sexual dysfunction: definitions, causes, and treatment. Urol Nurs 2002; 22: 237–244, 284; quiz 245, 248.

    PubMed  Google Scholar 

  3. Berman JR, Bassuk J . Physiology and pathophysiology of female sexual function and dysfunction. World J Urol 2002; 20: 111–118.

    Article  Google Scholar 

  4. Ashton AK, Hamer R, Rosen RC . Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997; 23: 165–175.

    Article  Google Scholar 

  5. Rosen RC, Lane RM, Menza M . Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999; 19: 67–85.

    Article  CAS  Google Scholar 

  6. Goldstein DJ, Rampey Jr AH, Enas GG, Potvin JH, Fludzinski LA, Levine LR . Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes Relat Metab Disord 1994; 18: 129–135.

    CAS  Google Scholar 

  7. National Heart, Lung, and Blood Institute Obesity Education Initiative. The Practical Guide Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute: Rockville, MD, October 2000. NIH Publication Number 00-4084.

  8. Finer N . Sibutramine: its mode of action and efficacy. Int J Obes Relat Metab Disord 2002; 26 (Suppl 4): S29–S33.

    Article  CAS  Google Scholar 

  9. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord 1998; 22 (Suppl 1): S18–S28.

    CAS  Google Scholar 

  10. WHO Global Strategy on Diet Physical Activity and Health: South-East Asia Regional Consultation Meeting Report, New Delhi, India, 10–12 March 2003.

  11. WHO Regional Office for the Western Pacific/International Association for the Study of Obesity/International Obesity Task Force. The Asia–Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia: Sydney, 2000.

  12. Brownell KD . The LEARN Program for Weight Management, 10th edn. American Health Publishing Co: Dallas, Texas, 2004.

    Google Scholar 

  13. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191–208.

    Article  CAS  Google Scholar 

  14. Meston CM, Frohlich PF . Update on female sexual function. Curr Opin Urol 2001; 11: 603–609.

    Article  CAS  Google Scholar 

  15. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888–893.

    Article  CAS  Google Scholar 

  16. Taylor AE . Polycystic ovary syndrome. Endocrinol Metab Clin N Am 1998; 27: 877–902.

    Article  CAS  Google Scholar 

  17. Adolfsson B, Elofsson S, Rossner S, Unden AL . Are sexual dissatisfaction and sexual abuse associated with obesity? A population-based study. Obes Res 2004; 12: 1702–1709.

    Article  Google Scholar 

  18. Arenton LW . Factors in the sexual satisfaction of obese women in relationships. Electron J Hum Sexuality 5, Available at: http://www.ejhs.org/volume5/Areton/TOC.htm. Accessed August 16, 2005.

  19. Kolotkin RL, Head S, Hamilton M, Tse CK . Assessing impact of weight on quality of life. Obes Res 1995; 3: 49–56.

    Article  CAS  Google Scholar 

  20. Werlinger K, King TK, Clark MM, Pera V, Wincze JP . Perceived changes in sexual functioning and body image following weight loss in an obese female population: a pilot study. J Sex Marital Ther 1997; 23: 74–78.

    Article  CAS  Google Scholar 

  21. Rand CS, Kuldau JM, Robbins L . Surgerry for obesity and marriage quality. JAMA 1982; 247: 1419–1422.

    Article  CAS  Google Scholar 

  22. Turcato E, Zamboni M, De Pergola G, Armellini F, Zivelonghi A, Bergamo-Andreis IA et al. Interrelationships between weight loss, body fat distribution and sex hormones in pre- and postmenopausal obese women. J Intern Med 1997; 241: 363–372.

    Article  CAS  Google Scholar 

  23. Dixon JB, O'Brien PE . Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss. Clin Endocrinol 2002; 57: 769–778.

    Article  CAS  Google Scholar 

  24. Hainer V, Kunesova M, Stunkard AJ, Parizkova J, Stich V, Mikulova R et al. The within-pair resemblance in serum levels of androgens, sex-hormone binding globulin and cortisol in female obese identical twins – effect of negative energy balance induced by very low-calorie diet. Horm Metab Res 2001; 33: 417–422.

    Article  CAS  Google Scholar 

  25. Jakubowicz DJ, Nestler JE . 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J Clin Endocrinol Metab 1997; 82: 556–560.

    CAS  PubMed  Google Scholar 

  26. Shifren JL . The role of androgens in female sexual dysfunction. Mayo Clin Proc 2004; 79 (Suppl 4): S19–S24.

    CAS  PubMed  Google Scholar 

  27. Sherwin BB, Gelfand MM, Brender W . Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985; 47: 339–351.

    Article  CAS  Google Scholar 

  28. Davis S, McCloud P, Strauss B, Burger H . Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1996; 21: 227–236.

    Article  Google Scholar 

  29. Stunkard AJ, Stinnett JL, Smoller JW . Psychological and social aspects of the surgical treatment of obesity. Am J Psychiatry 1986; 143: 417–429.

    Article  CAS  Google Scholar 

  30. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM et al. Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189–198.

    Article  CAS  Google Scholar 

  31. Smith IG, Goulder MA . Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract 2001; 50: 505–512.

    CAS  Google Scholar 

  32. Wadden TA, Foster GD, Wang J, Pierson RN, Yang MU, Moreland K et al. Clinical correlates of short- and long-term weight loss. Am J Clin Nutr 1992; 56 (Suppl 1): S271–S274.

    Article  Google Scholar 

  33. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119–2125.

    Article  CAS  Google Scholar 

  34. Krejs GJ . Metabolic benefits associated with sibutramine therapy. Int J Obes Relat Metab Disord 2002; 26 (Suppl 4): S34–S37.

    Article  CAS  Google Scholar 

  35. Sabuncu T, Ucar E, Birden F, Yasar O . The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects. Diabetes Nutr Metab 2004; 17: 103–107.

    CAS  PubMed  Google Scholar 

  36. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682–688.

    Article  CAS  Google Scholar 

  37. Baldwin DS . Depression and sexual dysfunction. Br Med Bull 2001; 57: 81–99.

    Article  CAS  Google Scholar 

  38. Clayton AH, McGarvey EL, Clavet GJ, Piazza L . Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ). Psychopharmacol Bull 1997; 33: 747–753.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea

    K K Kim, H C Kang, S S Kim & B B Youn

Authors
  1. K K Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H C Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S S Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B B Youn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H C Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, K., Kang, H., Kim, S. et al. Influence of weight reduction by sibutramine on female sexual function. Int J Obes 30, 758–763 (2006). https://doi.org/10.1038/sj.ijo.0803198

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803198

Keywords

This article is cited by

Search

Advanced search

Quick links